Xianjun Yu

Active 2007–2025

287
Papers
27,151
Citations
86
h-index
267
i10-index

Citations

Citations per year for Xianjun Yu1964: 1 citations1982: 1 citations1989: 1 citations1995: 1 citations2004: 1 citations2006: 1 citations2008: 4 citations2009: 13 citations2010: 27 citations2011: 44 citations2012: 37 citations2013: 60 citations2014: 75 citations2015: 60 citations2016: 82 citations2017: 111 citations2018: 121 citations2019: 535 citations2020: 882 citations2021: 1,304 citations2022: 1,452 citations2023: 1,396 citations2024: 2,642 citations2025: 1,533 citations2026: 37 citations1965–1981: no citations, so these years are not shown1983–1988: no citations, so these years are not shown1990–1994: no citations, so these years are not shown1996–2003: no citations, so these years are not shown2005: no citations, so this year is not shown2007: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,266 citing papers, 40.5% of this breakdownUnited States: 1,976 citing papers, 15.2% of this breakdownItaly: 459 citing papers, 3.5% of this breakdownGermany: 423 citing papers, 3.2% of this breakdownUnited Kingdom: 399 citing papers, 3.1% of this breakdownIndia: 315 citing papers, 2.4% of this breakdownJapan: 302 citing papers, 2.3% of this breakdownSouth Korea: 281 citing papers, 2.2% of this breakdownFrance: 226 citing papers, 1.7% of this breakdownAustralia: 221 citing papers, 1.7% of this breakdownSpain: 202 citing papers, 1.6% of this breakdownIran: 195 citing papers, 1.5% of this breakdown
0%40.5%Other 21.1%

Fields

  • Medicine44.5%
  • Biochemistry, Genetics and Molecular Biology39.9%
  • Immunology and Microbiology8.3%
  • Engineering2.4%
  • Materials Science1.3%
  • Nursing0.8%
  • Other2.8%

Topics

  • Pancreatic and Hepatic Oncology Research4.9%
  • Ferroptosis and cancer prognosis4.4%
  • Cancer Immunotherapy and Biomarkers3.2%
  • Immune cells in cancer3%
  • RNA modifications and cancer2.9%
  • Cancer-related molecular mechanisms research2.5%
  • Other79.1%

Coauthors

All papers

Open in search
  1. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

    Authors: , , , , , , , , , - Molecular Cancer 2021 cited by 2,300

  2. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

    Authors: , , , , , , , , - Journal of Hematology & Oncology 2022 cited by 834

  3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

    Authors: , , , , , , , , - Journal of Hematology & Oncology 2020 cited by 1,359

  4. The role of necroptosis in cancer biology and therapy

    Authors: , , , , , , , , , , - Molecular Cancer 2019 cited by 1,080

  5. Applications of single-cell sequencing in cancer research: progress and perspectives

    Authors: , , , , , , , - Journal of Hematology & Oncology 2021 cited by 602

  6. The role of collagen in cancer: from bench to bedside

    Authors: , , , , , , , , - Journal of Translational Medicine 2019 cited by 755

  7. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

    Authors: , , , , , - Signal Transduction and Targeted Therapy 2023 cited by 352

  8. Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives

    Authors: , , , , , , , , , , - Cancer Communications 2022 cited by 262

  9. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter

    Authors: , , , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020 cited by 427

  10. Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer

    Authors: , , , , , , , , , , - Cell Proliferation 2023 cited by 174

  11. Liquid–liquid phase separation in tumor biology

    Authors: , , , , , , - Signal Transduction and Targeted Therapy 2022 cited by 254

  12. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 718

  13. Functional significance of cholesterol metabolism in cancer: from threat to treatment

    Authors: , , , , , , , , , - Experimental & Molecular Medicine 2023 cited by 201

  14. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells

    Authors: , , , , , , , , , , , - Redox Biology 2020 cited by 286

  15. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment

    Authors: , , , , , , - Journal of Hematology & Oncology 2023 cited by 135

  16. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , - Journal of Hematology & Oncology 2020 cited by 312

  17. Histone lactylation: from tumor lactate metabolism to epigenetic regulation

    Authors: , , , , , , - International Journal of Biological Sciences 2024 cited by 120

  18. The microbiota and microbiome in pancreatic cancer: more influential than expected

    Authors: , , , , , , , , , - Molecular Cancer 2019 cited by 260

  19. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , - Gut 2023 cited by 100

  20. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

    Authors: , , , , , , , , , , - Molecular Cancer 2020 cited by 253

  21. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications

    Authors: , , , , , , - Acta Pharmacologica Sinica 2021 cited by 151

  22. Angiogenesis in pancreatic cancer: current research status and clinical implications

    Authors: , , , , , , , , , , , , - Angiogenesis 2018 cited by 290

  23. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer

    Authors: , , , , , , , , , , - Cancer Letters 2019 cited by 156

  24. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , - Biomaterials 2021 cited by 81